Hemab (Series B)
Funding Details
- Awarder
- Inbox
- Date Award
- February 21, 2023
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $135,000,000
Company Info
- Company Description
- Hemab is a clinical-stage biotech company developing prophylactic therapeutics for serious, underserved bleeding and thrombotic disorders.
- Market
- Therapeutics for bleeding and thrombotic disorders
- Location
- Cambridge, MA, USA
- Coinvestors
- Access Biotechnology, Avoro Ventures, Deep Track Capital, HealthCap, Invus, Maj Invest Equity, Novo Holdings, RA Capital Management, Rock Springs Capital